LataMed AI Corp. (OTC: LMED), a healthcare technology company specializing in digital health and artificial intelligence solutions for Latin America, announced a new agreement with the Venezuelan Institute for Scientific Research (IVIC) to develop a digital platform module. The module aims to streamline access to IVIC's designated laboratory and scientific services, potentially impacting healthcare, pharmaceuticals, food production, agriculture, and related industries in the region.
Under the agreement, LataMed AI's Venezuelan operating subsidiary, LATAMEDAI VE, will collaborate with IVIC on the design, development, testing, and implementation of a digital interface. This interface is intended to allow authorized business and institutional users to request laboratory services, schedule appointments, monitor request status, access approved reports and documentation, and complete authorized payment processes. The goal is to create a centralized digital workflow that simplifies access to these critical services.
Dr. Kevin Rodan Levy, CEO of LataMed AI, emphasized the significance of the partnership: "This agreement represents an opportunity to apply our technology to an important area of scientific and enterprise service delivery. Our objective is to work with IVIC to develop a responsible digital framework that makes it easier for authorized users to request services, manage appointments, monitor processes, and access approved information through a centralized platform."
The initiative marks a strategic expansion for LataMed AI, which has primarily focused on patient-facing telemedicine. Management believes this project will demonstrate the company's capability to support institutional and enterprise workflows involving healthcare, scientific services, laboratory coordination, and digital documentation. This aligns with LataMed AI's broader strategy of building digital infrastructure that connects patients, healthcare professionals, pharmacies, insurers, payment providers, wellness organizations, and other stakeholders in the healthcare and scientific-services ecosystem.
If successfully implemented, the module could serve as a adaptable framework for other institutional and enterprise service environments in Venezuela and elsewhere in Latin America. However, any future expansion would be subject to separate agreements, technical readiness, regulatory requirements, and the needs of participating institutions.
The agreement establishes the framework for collaboration but does not guarantee a specific implementation date, user adoption level, service volume, revenue, or profitability. The company will provide updates as development progresses. For more information, interested parties can visit LataMed AI's website at https://latamed.ai or review SEC filings at www.sec.gov.
This partnership highlights the growing role of digital platforms in facilitating access to essential scientific and laboratory services, which could lead to more efficient operations for businesses and institutions relying on such services. It also underscores LataMed AI's commitment to broadening its impact in Latin America's healthcare and scientific sectors.
